Loading clinical trials...

ACTIVE_NOT_RECRUITINGNA

Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care

NCT04838210•Washington University School of Medicine

Summary

This study will provide high-quality, representative data on the capacity of Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care (EleVATE GC) to reduce perinatal depression, preterm birth, and low birthweight in African-American women. If findings from this study indicate that EleVATE GC is feasible and effective, this model could be implemented nationwide to help achieve mental and obstetric health parity for low-income women of color in the United States.

Eligibility

Age

13 - No limit years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•English or Spanish speaking
•≤18 weeks' gestation
•Established prenatal care at EleVATE site
•High-risk for postpartum depression by ≥1 risk factor (personal/family history, baseline EPDS≥10, low-income, 13-19 years old, single, history of physical/sexual abuse, unplanned/undesired pregnancy, history of pregnancy loss)
•Ability to attend group prenatal visits at specified days/times
•Willingness to be randomized
•Ability to give informed consent
•Any patient that has received prenatal care in a group setting previously

Exclusion Criteria

•Multiple gestation
•Major fetal anomaly
•Serious medical co-morbidity/psychiatric illness necessitating more care than can be safely provided in group setting
•Serious medical co-morbidity necessitating more care than can be safely provided in group setting

Locations (4)

University of Missouri-Kansas City/Truman Health Centers-Kansas City

Kansas City, Missouri, United States

Affinia Healthcare

St Louis, Missouri, United States

Family Care Health Centers

St Louis, Missouri, United States

CareSTL Health

St Louis, Missouri, United States

Key Dates

Start Date

May 21, 2021

Primary Completion Date

December 3, 2025

Completion Date

June 30, 2026

Last Updated

January 20, 2026

Enrollment

416

ACTUAL participants

Conditions

Pregnancy RelatedPerinatal Depression

Interventions

EleVATE Group Care

BEHAVIORAL

Individual Prenatal Care

BEHAVIORAL

Comparison of Two Salpingectomy Techniques for Sterilization at the Time of Cesarean Delivery

NCT06273683

Permanent SterilizationPregnancy Related

View study

RECRUITING

Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation

NCT06258902

Pregnancy Related

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 20, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care

Inclusion Criteria

Exclusion Criteria

Comparison of Two Salpingectomy Techniques for Sterilization at the Time of Cesarean Delivery

Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation

Community-based Implementation of Adapted STAC

Dural Puncture Epidural vs Standard Epidural Analgesia in Labor

Effects of Systematic Cervical Exam Training on Labor and Delivery Care

Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population